Capivasertib is the first approved highly selective ATP-competitive AKT kinase inhibitor, and is commonly used in combination with fulvestrant.
Authentic
Guarantee
Fast Delivery
Privacy The price of capapasetinib is affected by dosage, region, and purchase channel. Currently, there is no publicly announced uniform price in China. In o···【More】
Update: 02 Apr,2026Source: BigbearViews: 122
Capivasertib (generic name: Capivasertib) is not yet officially available in the Chinese market. Actual costs are significantly affected by dosage, pu···【More】
Update: 02 Apr,2026Source: BigbearViews: 125
Complete English TranslationCapivasertibCapivasertib is an oral targeted anti-cancer drug. It should be stored in a cool, dry place at a temperature b···【More】
Update: 16 Mar,2026Source: BigbearViews: 114
Capivasertib is an oral small-molecule targeted drug whose primary mechanism of action involves inhibiting serine/threonine kinase. By blocking releva···【More】
Update: 16 Mar,2026Source: BigbearViews: 112
Capivasertib is an oral small-molecule targeted drug whose primary mechanism of action involves inhibiting serine/threonine kinase. By blocking releva···【More】
Update: 16 Mar,2026Source: BigbearViews: 112
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos